At ZS, we are excited to present our podcast on Pharma Global Strategy. Our experts, Jennifer Curtis, Nan Wang, and Cody Powers, delve into the trends in early and late-stage pharma acquisitions, providing key insights for a stronger global strategy. They highlight how innovation is becoming more diffuse in the increasingly fragmented pharma industry. Our podcast reveals that late-stage deals have significantly underperformed compared to early-stage strategies, with the difference rising two- or three-fold in some cases.
